Heather M Schmitt
University of Wisconsin-Madison
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Heather M Schmitt.
Molecular Neurodegeneration | 2014
Heather M Schmitt; Heather R. Pelzel; Cassandra L. Schlamp; Robert W. Nickells
BackgroundOptic nerve damage initiates a series of early atrophic events in retinal ganglion cells (RGCs) that precede the BAX-dependent committed step of the intrinsic apoptotic program. Nuclear atrophy, including global histone deacetylation, heterochromatin formation, shrinkage and collapse of nuclear structure, and the silencing of normal gene expression, comprise an important obstacle to overcome in therapeutic approaches to preserve neuronal function. Several studies have implicated histone deacetylases (HDACs) in the early stages of neuronal cell death, including RGCs. Importantly, these neurons exhibit nuclear translocation of HDAC3 shortly after optic nerve damage. Additionally, HDAC3 activity has been reported to be selectively toxic to neurons.ResultsRGC-specific conditional knockout of Hdac3 was achieved by transducing the RGCs of Hdac3fl/fl mice with an adeno-associated virus serotype 2 carrying CRE recombinase and GFP (AAV2-Cre/GFP). Controls included similar viral transduction of Rosa26fl/fl reporter mice. Optic nerve crush (ONC) was then performed on eyes. The ablation of Hdac3 in RGCs resulted in significant amelioration of characteristics of ONC-induced nuclear atrophy such as H4 deacetylation, heterochromatin formation, and the loss of nuclear structure. RGC death was also significantly reduced. Interestingly, loss of Hdac3 expression did not lead to protection against RGC-specific gene silencing after ONC, although this effect was achieved using the broad spectrum inhibitor, Trichostatin A.ConclusionAlthough other HDACs may be responsible for gene expression changes in RGCs, our results indicate a critical role for HDAC3 in nuclear atrophy in RGC apoptosis following axonal injury. This study provides a framework for studying the roles of other prevalent retinal HDACs in neuronal death as a result of axonal injury.
Neuroscience Letters | 2016
Heather M Schmitt; Cassandra L. Schlamp; Robert W. Nickells
Optic neuropathies are characterized by retinal ganglion cell (RGC) death, resulting in the loss of vision. In glaucoma, the most common optic neuropathy, RGC death is initiated by axonal damage, and can be modeled by inducing acute axonal trauma through procedures such as optic nerve crush (ONC) or optic nerve axotomy. One of the early events of RGC death is nuclear atrophy, and is comprised of RGC-specific gene silencing, histone deacetylation, heterochromatin formation, and nuclear shrinkage. These early events appear to be principally regulated by epigenetic mechanisms involving histone deacetylation. Class I histone deacetylases HDACs 1, 2, and 3 are known to play important roles in the process of early nuclear atrophy in RGCs, and studies using both inhibitors and genetic ablation of Hdacs also reveal a critical role in the cell death process. Select inhibitors, such as those being developed for cancer therapy, may also provide a viable secondary treatment option for optic neuropathies.
Investigative Ophthalmology & Visual Science | 2017
Robert W. Nickells; Heather M Schmitt; Margaret E. Maes; Cassandra L. Schlamp
Purpose Gene therapy of retinal ganglion cells (RGCs) has promise as a powerful therapeutic for the rescue and regeneration of these cells after optic nerve damage. However, early after damage, RGCs undergo atrophic changes, including gene silencing. It is not known if these changes will deleteriously affect transduction and transgene expression, or if the therapeutic protein can influence reactivation of the endogenous genome. Methods Double-transgenic mice carrying a Rosa26-(LoxP)-tdTomato reporter, and a mutant allele for the proapoptotic Bax gene were reared. The Bax mutant blocks apoptosis, but RGCs still exhibit nuclear atrophy and gene silencing. At times ranging from 1 hour to 4 weeks after optic nerve crush (ONC), eyes received an intravitreal injection of AAV2 virus carrying the Cre recombinase. Successful transduction was monitored by expression of the tdTomato reporter. Immunostaining was used to localize tdTomato expression in select cell types. Results Successful transduction of RGCs was achieved at all time points after ONC using AAV2 expressing Cre from the phosphoglycerate kinase (Pgk) promoter, but not the CMV promoter. ONC promoted an increase in the transduction of cell types in the inner nuclear layer, including Müller cells and rod bipolar neurons. There was minimal evidence of transduction of amacrine cells and astrocytes in the inner retina or optic nerve. Conclusions Damaged RGCs can be transduced and at least some endogenous genes can be subsequently activated. Optic nerve damage may change retinal architecture to allow greater penetration of an AAV2 virus to transduce several additional cell types in the inner nuclear layer.
Investigative Ophthalmology & Visual Science | 2017
Robert W. Nickells; Cassandra L. Schlamp; Heather M Schmitt
Investigative Ophthalmology & Visual Science | 2017
Heather M Schmitt; Cassandra L. Schlamp; Huan Yang; Lian-Wang Guo; Robert W. Nickells
Investigative Ophthalmology & Visual Science | 2016
Robert W. Nickells; Cassandra L. Schlamp; Heather M Schmitt; Bikash R. Pattnaik
Investigative Ophthalmology & Visual Science | 2016
Heather M Schmitt; Cassandra L. Schlamp; Robert W. Nickells
Investigative Ophthalmology & Visual Science | 2015
Heather M Schmitt; Cassandra L. Schlamp; Robert W. Nickells
Investigative Ophthalmology & Visual Science | 2014
Janis T. Eells; Betsy Abroe; Heather M Schmitt; Alina González-Quevedo; Phyllis Summerfelt; Joseph Carroll; Sandeep Gopalakrishnan
Investigative Ophthalmology & Visual Science | 2013
Janis T. Eells; Sandeep Gopalakrishnan; Mahsa Ranji; Sepideh Maleki; Betsy Abroe; Heather M Schmitt; Phyllis Summerfelt; Joseph Carroll